JP2024528284A5 - - Google Patents
Info
- Publication number
- JP2024528284A5 JP2024528284A5 JP2024507165A JP2024507165A JP2024528284A5 JP 2024528284 A5 JP2024528284 A5 JP 2024528284A5 JP 2024507165 A JP2024507165 A JP 2024507165A JP 2024507165 A JP2024507165 A JP 2024507165A JP 2024528284 A5 JP2024528284 A5 JP 2024528284A5
- Authority
- JP
- Japan
- Prior art keywords
- mutant
- nucleic acid
- osteoporosis
- acid molecule
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230707P | 2021-08-07 | 2021-08-07 | |
| US63/230,707 | 2021-08-07 | ||
| PCT/US2022/074307 WO2023019067A1 (en) | 2021-08-07 | 2022-07-29 | Methods of treating decreased bone mineral density with cluster of differentiation 109 (cd109) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528284A JP2024528284A (ja) | 2024-07-26 |
| JP2024528284A5 true JP2024528284A5 (cg-RX-API-DMAC7.html) | 2025-08-04 |
Family
ID=83004518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507165A Pending JP2024528284A (ja) | 2021-08-07 | 2022-07-29 | 分化抗原群109(cd109)阻害剤で骨ミネラル密度低下を治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11891607B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4381066A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024528284A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240046531A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118541481A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022325199A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3227109A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310276A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023019067A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024210666A1 (ko) | 2023-04-07 | 2024-10-10 | 주식회사 케이티 | 전이중통신에서 하향링크 데이터 채널을 송수신하는 방법 및 장치 |
-
2022
- 2022-07-29 CA CA3227109A patent/CA3227109A1/en active Pending
- 2022-07-29 US US17/816,084 patent/US11891607B2/en active Active
- 2022-07-29 CN CN202280060863.0A patent/CN118541481A/zh active Pending
- 2022-07-29 EP EP22757807.7A patent/EP4381066A1/en active Pending
- 2022-07-29 AU AU2022325199A patent/AU2022325199A1/en active Pending
- 2022-07-29 KR KR1020247007215A patent/KR20240046531A/ko active Pending
- 2022-07-29 WO PCT/US2022/074307 patent/WO2023019067A1/en not_active Ceased
- 2022-07-29 JP JP2024507165A patent/JP2024528284A/ja active Pending
- 2022-07-29 IL IL310276A patent/IL310276A/en unknown
-
2023
- 2023-12-21 US US18/392,181 patent/US12234460B2/en active Active
-
2025
- 2025-01-22 US US19/033,694 patent/US20250236873A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101770435B1 (ko) | 자연 안티센스 전사체가 아포리포단백질-a1로 억제에 의해 아포리포단백-a1 관련된 질환의 치료 | |
| RU2551234C2 (ru) | Лечение сиртуин 1 (sirt1)-связанных заболеваний путем ингибирования натурального антисмыслового транскрипта | |
| JP5039172B2 (ja) | Smad7に対するアンチセンスオリゴヌクレオチド(ODN)及びその医療分野での使用 | |
| JP2010534195A (ja) | アルテミン及び関連するリガンドについてのポリペプチド及びポリヌクレオチド、並びにその使用方法 | |
| US20150291954A1 (en) | Organic compositions to treat beta-catenin-related diseases | |
| CN104684927B (zh) | 用于治疗与herv-w包膜蛋白表达相关的疾病中的髓鞘再生阻断的化合物 | |
| WO2025112188A1 (zh) | Zfp217基因在制备治疗骨质疏松的药物中的应用 | |
| JP2024524375A5 (cg-RX-API-DMAC7.html) | ||
| Zhang et al. | ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk‐JNK Through DOK3 | |
| Li et al. | Intra-articular injection of miRNA-1 agomir, a novel chemically modified miRNA agonists alleviates osteoarthritis (OA) progression by downregulating Indian hedgehog in rats | |
| US10449200B2 (en) | Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer | |
| JP2024541089A5 (cg-RX-API-DMAC7.html) | ||
| EP1578939A2 (en) | Translational control by small, non-translatable rnas | |
| WO2004016739A2 (en) | Cell modulation using a cytoskeletal protein | |
| JP2024524388A5 (cg-RX-API-DMAC7.html) | ||
| KR101121987B1 (ko) | 파골세포 골흡수 억제 siRNA 발현 벡터 및 이를 이용한 유전자 치료제 | |
| JP6407912B2 (ja) | ヘモグロビン(hbf/hbg)に対する天然アンチセンス転写物の抑制によるhbf/hbg関連疾患の治療 | |
| Duan et al. | Pengcui Li, Yangyang Gao 2, 7, Raorao Zhou, Xianda Che, Hang Wang, Lingling Cong, Pinpin Jiang, Dan Liang, Penghua Li 3, Chunfang Wang 4, Wenjin Li 5, Shengbo Sang 6 | |
| Mitsutake et al. | BRAF mediates RET/PTC-induced MAPK activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis | |
| Li | Overexpression of Wnt5a in Bone Marrow-Derived Macrophages Promotes Osteoarthritis Progression | |
| CN119700934A (zh) | Meis1在制备子宫内膜异位症治疗剂中的应用及其制备的治疗剂 | |
| CN108339119A (zh) | miR-146a及其靶点在治疗骨关节炎中的应用 | |
| WO2017126655A1 (ja) | 疼痛の予防または治療用医薬組成物およびRobo4を用いる疼痛抑制物質のスクリーニング方法 | |
| JP2024524526A5 (cg-RX-API-DMAC7.html) | ||
| CN120771279A (zh) | Prmt6抑制剂在制备抗骨吸收产品中的用途 |